"People with drug-resistant tuberculosis in India could soon have access to critical medication at a far lower cost after the authorities rejected US pharmaceutical giant Johnson & Johnson’s application to extend a patent."

https://www.theguardian.com/global-development/2023/mar/29/victory-over-big-pharma-opens-door-to-cheaper-tuberculosis-drugs-india